These data suggest that inhibiting HP1α in tumor-specific human CD4+ T cells could, as it does in allospecific murine Tconv (Fig. 3c, d), repress the establishment of the exhaustion program and thus promote a protective immune response. This evidence concerns the gene CD4 and neoplasm.